Biological Hazards and Emerging Exposures

5 minutes 5 Questions

Biological hazards (biohazards) are living organisms or their byproducts that can cause illness, infection, allergic reaction, or toxic effects in exposed workers. In the Certified Safety Professional (CSP) body of knowledge and occupational health practice, they are classified as a distinct hazard category alongside chemical, physical, ergonomic, and psychosocial hazards. Common agents include bacteria (e.g., Legionella, tuberculosis), viruses (hepatitis B/C, HIV, influenza, SARS-CoV-2), fungi and molds, parasites, prions, and biological toxins such as endotoxins and mycotoxins. Exposure routes include inhalation of bioaerosols, percutaneous injury (needlesticks), mucous membrane contact, ingestion, and vector transmission. High-risk industries include healthcare, laboratories, agriculture, waste and wastewater treatment, food processing, veterinary services, and emergency response. Regulatory and consensus frameworks guide control: OSHA's Bloodborne Pathogens Standard (29 CFR 1910.1030) requires exposure control plans, universal precautions, engineering controls like sharps-safety devices, hepatitis B vaccination, and post-exposure follow-up. CDC/NIH Biosafety in Microbiological and Biomedical Laboratories defines Biosafety Levels 1–4, matching containment practices and facility design to agent risk. The hierarchy of controls applies: elimination/substitution, engineering (biosafety cabinets, HEPA filtration, ventilation, negative pressure rooms), administrative (training, medical surveillance, immunization, decontamination procedures), and personal protective equipment (respirators, gloves, gowns, eye protection). Emerging exposures reflect evolving work environments and science. Examples include pandemic pathogens and zoonotic spillover driven by globalization and climate change; antimicrobial-resistant organisms; mold and indoor air quality concerns in water-damaged buildings; bioaerosols in cannabis cultivation and composting; engineered nanomaterials with uncertain toxicology; synthetic biology and gene-editing laboratory risks; and vector-borne diseases expanding into new regions, affecting outdoor workers. The COVID-19 pandemic highlighted gaps in respiratory protection programs, ventilation adequacy, and infectious disease preparedness beyond healthcare. For the CSP, competency means anticipating these hazards through risk assessment, applying industrial hygiene sampling and exposure assessment methods, integrating occupational medicine (surveillance, vaccination, fitness for duty), and developing adaptable emergency and continuity plans that protect workers against both known and novel biological threats.

Biological Hazards and Emerging Exposures: A Complete CSP Exam Guide (Occupational Health and Applied Science)

Why This Topic Matters on the CSP Exam
The BCSP Certified Safety Professional exam blueprint places Biological Hazards and Emerging Exposures within the Occupational Health and Applied Science domain. BCSP expects a CSP to anticipate, recognize, evaluate, and control biological agents just as competently as chemical or physical hazards. The COVID-19 pandemic, outbreaks of Legionnaires disease, needlestick injuries in healthcare, mold in water-damaged buildings, and the rapid growth of nanotechnology and biotechnology have made this a high-visibility area. Exam questions in this area tend to test (1) terminology and classification, (2) routes of exposure and the chain of infection, (3) the OSHA Bloodborne Pathogens standard (29 CFR 1910.1030), (4) biosafety levels and containment, (5) control strategies ordered by the hierarchy of controls, and (6) awareness of new or poorly characterized hazards such as engineered nanomaterials, pandemics, and antimicrobial resistance. Because the CSP exam is a practice-level test, questions will often describe a scenario and ask for the best, first, or most effective action rather than simple recall.

What Biological Hazards Are
A biological hazard (biohazard) is any living organism, or product of a living organism, capable of causing adverse health effects in humans. Major categories include:
• Bacteria – e.g., Legionella pneumophila, Mycobacterium tuberculosis, Bacillus anthracis (anthrax), Brucella, Coxiella burnetii (Q fever), tetanus.
• Viruses – Hepatitis B (HBV), Hepatitis C (HCV), HIV, influenza, SARS-CoV-2, rabies, hantavirus, measles, norovirus.
• Fungi and molds – Stachybotrys, Aspergillus, Histoplasma capsulatum (bird and bat droppings), Coccidioides (Valley fever in soil disturbance).
• Parasites and protozoa – Giardia, Cryptosporidium, malaria (vector-borne).
• Prions – misfolded proteins causing CJD; extremely resistant to standard sterilization.
• Biological toxins and by-products – endotoxins (from gram-negative cell walls, common in organic dusts and metalworking fluids), mycotoxins, botulinum toxin, ricin.
• Allergens and sensitizers – animal dander, latex proteins, flour dust, enzymes, bird proteins (hypersensitivity pneumonitis, occupational asthma).
• Vectors and animals – ticks (Lyme disease), mosquitoes (West Nile, Zika), rodents (hantavirus, leptospirosis), and bites or scratches from animals (rabies, zoonoses).

Workers at elevated risk include healthcare and laboratory staff, first responders, waste and wastewater workers, agricultural and veterinary workers, custodians, HVAC technicians, remediation contractors, and anyone working outdoors or in flooded or neglected buildings.

What Emerging Exposures Are
Emerging exposures are hazards that are new, newly recognized, rapidly changing, or lack established occupational exposure limits and consensus control methods. On the CSP exam this phrase typically includes:
• Emerging infectious diseases and pandemics – SARS-CoV-2, novel influenza strains, Ebola, MERS, mpox, and the growing problem of antimicrobial-resistant organisms (MRSA, CRE).
• Engineered nanomaterials – particles with at least one dimension between 1 and 100 nanometers (carbon nanotubes, nano-titanium dioxide, nano-silver). Toxicity depends on size, surface area, shape, and surface chemistry rather than mass alone. NIOSH has published Recommended Exposure Limits of 1 microgram per cubic meter (elemental carbon, respirable) for carbon nanotubes and nanofibers, and 0.3 milligrams per cubic meter for ultrafine titanium dioxide.
• Biotechnology and synthetic biology – recombinant DNA, gene editing (CRISPR), cell and gene therapies, and large-scale fermentation, governed by the NIH Guidelines and CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL).
• Additive manufacturing (3D printing) emissions of ultrafine particles and VOCs, and other advanced-manufacturing exposures.
• Climate-driven hazards – expanding geographic range of vector-borne disease, more frequent flooding (mold, sewage), wildfire smoke, and heat stress interacting with biological risk.
• Psychosocial and organizational changes that alter exposure patterns, such as remote and gig work, which the CSP blueprint may reference alongside emerging physical and biological risks.
The common thread is uncertainty: limited toxicological data, no PEL, evolving guidance, and a need for the precautionary principle and prudent practices rather than compliance with a numeric limit.

How Biological Exposure Works: The Chain of Infection
Exam questions frequently test the six links in the chain of infection, because every control strategy works by breaking one or more links:
1. Infectious agent – the pathogen; characterized by infectivity, pathogenicity, virulence, and infective dose.
2. Reservoir – where the agent lives and multiplies (humans, animals, soil, water, cooling towers, HVAC systems).
3. Portal of exit – blood, respiratory secretions, feces, aerosolized water.
4. Mode of transmission – direct contact, indirect contact (fomites), droplet (greater than 5 microns, travels roughly 3 to 6 feet), airborne (droplet nuclei under 5 microns remain suspended), vector-borne, vehicle-borne (food, water), and percutaneous (needlestick).
5. Portal of entry – inhalation, ingestion, mucous membranes, non-intact skin, injection.
6. Susceptible host – influenced by immune status, vaccination, age, pregnancy, and immunosuppression.

Routes of occupational exposure that the exam expects you to recognize: inhalation (most important for TB, Legionella, mold, anthrax spores), percutaneous/parenteral (needlesticks, cuts, bites), mucous membrane (splashes to eyes, nose, mouth), ingestion (hand-to-mouth, contaminated food), and dermal contact through broken skin.

Key Standards, Guidelines, and Numbers to Know
OSHA Bloodborne Pathogens Standard, 29 CFR 1910.1030 (amended by the Needlestick Safety and Prevention Act of 2000):
• Applies to employees with reasonably anticipated occupational exposure to blood or other potentially infectious materials (OPIM).
• Requires a written Exposure Control Plan reviewed and updated at least annually, including an exposure determination by job classification and documentation of consideration of safer medical devices with input from frontline non-managerial employees.
• Universal (Standard) Precautions – treat all human blood and OPIM as infectious.
• Engineering controls – sharps with engineered sharps injury protections, needleless systems, sharps containers that are puncture-resistant, leak-proof, labeled, and closable.
• Work practice controls – no recapping, bending, or shearing needles (one-handed scoop or mechanical device only when no alternative exists); handwashing; no eating or applying cosmetics in exposure areas.
• PPE provided at no cost; gloves, gowns, face shields, resuscitation devices.
• Hepatitis B vaccination offered free within 10 working days of initial assignment; employee may decline with a signed declination form and may later accept.
• Post-exposure evaluation and follow-up – confidential medical evaluation, source individual testing when feasible, counseling, post-exposure prophylaxis; healthcare professional written opinion provided to the employee within 15 days.
• Labels – fluorescent orange or orange-red biohazard warning label, or red bags/containers.
• Sharps injury log required for employers who must keep OSHA 300 logs; needlestick injuries from contaminated sharps are recordable and must be entered as a privacy case.
• Training at initial assignment and at least annually.
• Records – medical records retained for duration of employment plus 30 years; training records for 3 years.
Approximate seroconversion risk after a contaminated needlestick: HBV 6 to 30 percent (unvaccinated), HCV about 1.8 percent, HIV about 0.3 percent (about 0.09 percent for mucous membrane exposure).

Biosafety Levels (CDC/NIH BMBL):
• BSL-1 – agents not known to cause disease in healthy adults; standard microbiological practices; open bench work.
• BSL-2 – moderate-risk agents (HBV, Salmonella, Staphylococcus aureus); limited access, biohazard signs, biological safety cabinet for aerosol-generating procedures, autoclave available.
• BSL-3 – indigenous or exotic agents with potential for aerosol transmission and serious disease (TB, SARS-CoV-2 culture, Coxiella); controlled access, directional inward airflow, all work in BSC, respiratory protection as needed, double-door entry.
• BSL-4 – dangerous and exotic agents with high risk of life-threatening disease and no treatment (Ebola, Marburg); Class III cabinets or positive-pressure suits, dedicated supply and exhaust, decontamination showers.
Agents are also assigned to Risk Groups 1 to 4 by the NIH Guidelines; the risk group describes the agent, while the BSL describes the combination of practices, equipment, and facility design.

Biological Safety Cabinets:
• Class I – protects worker and environment, not the product; inward airflow with HEPA-filtered exhaust.
• Class II (Types A1, A2, B1, B2) – protects worker, product, and environment; HEPA-filtered downflow and exhaust; most common in labs. Type B2 is 100 percent exhausted and used with volatile chemicals or radionuclides.
• Class III – gas-tight glove box, highest containment, used at BSL-4.
A horizontal or vertical laminar flow clean bench protects the product only and blows air toward the worker; it is never appropriate for infectious material.

Tuberculosis and Airborne Precautions: airborne infection isolation rooms under negative pressure with at least 12 air changes per hour (6 ACH in existing facilities), exhaust to outside or through HEPA, and NIOSH-certified N95 or higher respirator as the minimum; healthcare workers screened with TST or IGRA. Remember ACH = (Q in cfm times 60) divided by room volume in cubic feet.

Legionella: grows between about 20 and 50 degrees C (68 to 122 degrees F), optimally around 35 degrees C; amplified in cooling towers, hot water tanks, decorative fountains, showers, and stagnant dead legs. Transmission is by inhalation of aerosolized water; it is not spread person to person. Controls follow ASHRAE Standard 188 water management programs: store hot water above 60 degrees C (140 degrees F), deliver above 51 degrees C (124 degrees F), keep cold water below 20 degrees C, maintain disinfectant residual, control scale and biofilm, drift eliminators on cooling towers, and flush stagnant lines.

Mold: there is no OSHA PEL or validated dose-response standard, so sampling is rarely the first step; the control principle is moisture control. EPA guidance suggests areas under about 10 square feet may be handled by trained maintenance staff with basic PPE, while larger areas warrant containment, negative air with HEPA filtration, and respiratory protection (N95 minimum, often half-face or full-face with P100). Dry wet materials within 24 to 48 hours to prevent growth; porous materials that cannot be dried and cleaned are discarded.

Zoonoses and vector-borne disease: anthrax (inhalation form historically called wool sorters disease; cutaneous most common), brucellosis (unpasteurized dairy, slaughterhouses), Q fever (livestock birth products), hantavirus (rodent droppings; wet-cleaning rather than sweeping), histoplasmosis (bird and bat droppings in soil disturbance, demolition), psittacosis (birds), leptospirosis (rodent urine in water), rabies (post-exposure prophylaxis is essential), Lyme disease (deer ticks). Controls include vaccination where available, animal handling procedures, pest control, wetting methods to suppress dust, PPE, and medical surveillance.

Decontamination hierarchy: cleaning (physical removal) comes first, then disinfection (kills most pathogens but not necessarily spores; EPA-registered hospital disinfectants, or fresh 1:10 to 1:100 household bleach solution), then sterilization (destroys all microbial life including spores; steam autoclave at 121 degrees C and 15 psi for at least 15 to 30 minutes, ethylene oxide, hydrogen peroxide vapor). Prions require extended autoclaving and sodium hydroxide treatment. Regulated medical waste is handled per state rules and typically autoclaved or incinerated.

How Controls Work: Applying the Hierarchy
Exam answers almost always follow the hierarchy of controls:
1. Elimination/Substitution – needleless IV systems, replacing attenuated strains for virulent ones, eliminating stagnant water lines, using less hazardous animal models.
2. Engineering controls – biological safety cabinets, sharps containers, safety-engineered sharps, negative-pressure rooms, local exhaust ventilation, HEPA filtration, UVGI, enclosed processes for nanomaterial handling, autoclaves, water treatment systems.
3. Administrative controls – exposure control plan, standard precautions, vaccination programs, medical surveillance, training, housekeeping, restricted access, work scheduling, water management plans, pandemic preparedness plans, travel policies.
4. PPE – gloves, gowns, eye and face protection, respirators (N95 for airborne pathogens; PAPRs for high-risk aerosol-generating procedures; P100 for nanomaterial dusts). PPE is always the last line of defense and must be paired with a written respiratory protection program under 29 CFR 1910.134 and fit testing.

For emerging exposures without established limits, the exam expects a precautionary, control-banding, and prudent-practices approach: characterize the hazard as well as possible, assume potential for harm, enclose and ventilate, minimize the number of exposed workers and duration, use wet methods and HEPA-filtered vacuums for nanopowders, implement medical surveillance, document exposures, and stay current with NIOSH, CDC, WHO, and consensus guidance (NIOSH Current Intelligence Bulletins, ISO/TS 12901 for nanomaterials, ASHRAE 188, BMBL, NIH Guidelines). Pandemic planning includes infectious disease preparedness and response plans, hazard assessments by exposure risk level (very high, high, medium, lower), source control, ventilation upgrades, physical distancing, screening, telework, and sick leave policies that do not punish reporting.

Medical Surveillance and Recordkeeping
Baseline and periodic medical evaluations, immunization programs (HBV, influenza, tetanus, rabies for animal workers, others per Advisory Committee on Immunization Practices), TB screening, post-exposure protocols with defined timelines, confidentiality, and retention of exposure and medical records for duration of employment plus 30 years are recurring exam items. Work-related illnesses such as Legionnaires disease, TB conversion, or a needlestick with a contaminated sharp are OSHA recordable; needlesticks and bloodborne exposures are privacy concern cases.

Exam Tips: Answering Questions on Biological Hazards and Emerging Exposures
1. Identify the route of exposure first. If the scenario involves aerosols, think inhalation, ventilation, negative pressure, HEPA, and respirators. If it involves sharps or splashes, think bloodborne pathogens, engineering controls on devices, universal precautions, and post-exposure follow-up.
2. Apply the hierarchy of controls literally. When asked for the most effective control, choose elimination or engineering (needleless systems, BSC, enclosure) over PPE. When asked for the first step, choose assessment: exposure determination, hazard identification, or risk assessment, not purchasing respirators.
3. Know the regulatory anchors. Bloodborne pathogens is a true OSHA standard (1910.1030) with specific timelines (vaccine within 10 working days, written opinion within 15 days, annual plan review and training, records for employment plus 30 years). Mold, Legionella, nanomaterials, and most infectious diseases are governed by guidelines and the General Duty Clause (Section 5(a)(1)), not a PEL. Watch for distractors that invent an OSHA PEL for mold.
4. Match BSL to agent and practice. BSL-2 is the typical clinical lab level; BSL-3 adds inward airflow and all work in BSCs for aerosol-transmissible agents; BSL-4 means suits or Class III cabinets. Do not confuse Risk Group (the agent) with Biosafety Level (practices plus facility).
5. Separate cabinet types. Class II BSC protects worker, product, and environment. A clean bench protects only the product and is a wrong answer for infectious work. Class III is for BSL-4.
6. Memorize the key numbers. Droplet versus airborne size cutoff (about 5 microns), AII room ACH (12 new, 6 existing), Legionella growth range (20 to 50 degrees C) and hot water set points (above 60 degrees C storage), autoclave conditions (121 degrees C, 15 psi), seroconversion risks (HBV 6 to 30 percent, HCV about 1.8 percent, HIV about 0.3 percent), nanomaterial size (1 to 100 nm), NIOSH RELs for CNT (1 microgram per cubic meter) and ultrafine TiO2 (0.3 mg per cubic meter).
7. Break the chain of infection. If a question asks how a control works, link it to a chain element: vaccination removes the susceptible host, disinfection attacks the agent, water treatment attacks the reservoir, negative pressure interrupts transmission, PPE blocks the portal of entry.
8. For emerging hazards, choose precaution and documentation. The correct answer usually involves treating the material as potentially hazardous, enclosing and ventilating, minimizing exposed personnel, instituting medical surveillance, and consulting current NIOSH or CDC guidance, rather than waiting for a regulatory limit or declaring the exposure safe because no PEL exists.
9. Recognize moisture as the root cause of mold. Sampling is rarely necessary; fix the water intrusion, dry within 24 to 48 hours, remove porous contaminated materials, and scale containment to the size of the affected area.
10. Think zoonoses in agriculture, demolition, and outdoor work. Bird droppings point to histoplasmosis, rodent droppings to hantavirus (wet methods, no dry sweeping), livestock to brucellosis and Q fever, ticks to Lyme disease, and animal bites to rabies and immediate medical evaluation.
11. Do not forget recordkeeping and privacy. Needlesticks with contaminated sharps are recordable, go on the sharps injury log, and are privacy cases on the OSHA 300 log.
12. Read for qualifiers. Words such as minimum, most protective, required, recommended, first, and best change the answer. Eliminate choices that rely solely on PPE, that skip hazard assessment, or that contradict the hierarchy of controls, and select the response grounded in a recognized standard or consensus guideline.

Quick Review Summary
Biological hazards include bacteria, viruses, fungi, parasites, prions, toxins, and allergens, transmitted by inhalation, percutaneous injury, mucous membranes, ingestion, and dermal contact. Control them by breaking the chain of infection using the hierarchy of controls, with the OSHA Bloodborne Pathogens standard, CDC/NIH BMBL biosafety levels, ASHRAE 188, and NIOSH guidance as your technical anchors. Emerging exposures such as pandemics, nanomaterials, biotechnology, and climate-driven disease spread demand a precautionary approach, strong hazard assessment, medical surveillance, and continuous updating of knowledge. On the exam, identify the route, apply the hierarchy, cite the right standard or guideline, and remember the key numbers.
Test mode:

CSP - Biological Hazards and Emerging Exposures Example Questions

Test your knowledge of Biological Hazards and Emerging Exposures

Question 1

Why has ACGIH declined to set general threshold limit values for culturable or countable bioaerosols, such as total airborne fungi or bacteria?

Question 2

A maintenance worker develops Legionnaires' disease, and the local health department links the case to the building's cooling tower. A contractor has since hyperchlorinated and cleaned the tower. The facility manager asks the safety manager which measure will BEST prevent a recurrence over the long term. Which approach should the safety manager recommend?

Question 3

After a roof leak, office occupants report respiratory irritation. The safety manager collects paired spore-trap air samples. Indoor total spore counts are below the outdoor baseline. However, the indoor samples are dominated by Penicillium/Aspergillus and Chaetomium. The outdoor samples are dominated by Cladosporium. The facilities manager proposes closing the case because indoor counts are lower than outdoor counts. What do these results BEST indicate, and what should follow?

More Biological Hazards and Emerging Exposures questions
20 questions (total)